Afshin Ehsan, MD, Adam P. McGraw, PhD, Mark J

Slides:



Advertisements
Similar presentations
In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,
Advertisements

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Cell transplantation to prevent heart failure: a comparison of cell types  Takeshiro Fujii, MD, Terrence M Yau, MD, MS, Richard D Weisel, MD, Nobuhisa.
Lymphatic Vessel Memory Stimulated by Recurrent Inflammation
Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats  Yoshihide Mitani, MD, PhD,
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Heat shock protein 27: Induction by gastroduodenal reflux in vivo and augmentation of human esophageal mucosal cell growth in vitro  David Mauchley, MD,
Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription.
MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells  Mi Zhang, MD, Xiaohong Liu, MD, Xiwu Zhang, MD, Zhigang Song, MD, Lin Han,
Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps  Rahmi Oklu,
Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms  Xuan Zhang, PhD, Sean Thatcher, PhD,
A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: Evolving.
Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related.
George D. Webb, PhD, Lay Har Lim, BSc, Vernon M. S
Definition of proximal anastomosis in the doors study
Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass  Michael P. Robich, MD,
Three arteries versus the saphenous vein for coronary artery bypass graft: Why use a damaged graft to repair a damaged heart?  Andrzej Loesch, PhD, DSc,
Brahma-related gene 1 inhibits proliferation and migration of human aortic smooth muscle cells by directly up-regulating Ras-related associated with diabetes.
Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery  Julie A.A.
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation  Hongliang Cong, MD,
Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting 
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Michael G. Katz, MD, PhD, Elizabeth Brandon-Warner, PhD, Anthony S
Α1-Adrenergic receptors mediate combined signals initiated by mechanical stretch stress and norepinephrine leading to accelerated mouse vein graft atherosclerosis 
Occlusion of canine atrial appendage using an expandable silicone band
Vida K. Stark, MS, Thomas F. Warner, MD, John R. Hoch, MD 
Thomas E. Arnold, MD, Dmitri Gnatenko, PhD, Wadie F. Bahou, MD 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Pioglitazone preserves vein graft integrity in a rat aortic interposition model  Zhi Chen, MD, Tomomi Hasegawa, MD, PhD, Akiko Tanaka, MD, Yutaka Okita,
Right internal thoracic artery or saphenous vein grafting
Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: Role of Smad1 and extracellular signal-regulated.
Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype  Motoaki Ohnaka, MD, Akira Marui, MD, PhD,
Michael A. Golden, MD, Y. P. Tina Au, PhD, Richard D
Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury  Toshihiro Okamoto, MD, PhD, Xiaoying Tang, MS, Allison Janocha, BS, Caral.
In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the.
Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor  Matthias.
Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins  Xavier Berard, MD, PhD, Sébastien Déglise, MD, Florian Alonso, PhD,
Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin–Angiotensin System  Chiyo Ootaki, MD, Michifumi Yamashita, MD, PhD, Yoshio.
Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines:
The lord of the rings  Antonio Miceli, MD, PhD 
Masakuni Kido, MD, Lingling Du, MD, Christopher C
Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors  Mohammad H. Eslami, MD, Sidhu P. Gangadharan, MD,
Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac.
Aldosterone and Mineralocorticoid Receptor Antagonists Modulate Elastin and Collagen Deposition in Human Skin  Thomas F. Mitts, Severa Bunda, Yanting.
A self-renewing, tissue-engineered vascular graft for arterial reconstruction  Kei Torikai, MD, Hajime Ichikawa, MD, PhD, Koichiro Hirakawa, MS, Goro Matsumiya,
Nerve growth factor induces type III collagen production in chronic allergic airway inflammation  Ayşe Kılıç, MSc, Sanchaita Sriwal Sonar, PhD, Ali Oender.
Giant vein graft pseudoaneurysm with pulmonary hemorrhage
Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: Results from the Radial Artery Patency.
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years 
Lisheng Zhang, MD, Leigh Brian, MS, Neil J. Freedman, MD 
The bad guy, good guy scenario with a scimitar sword: A case to learn from  Hani K. Najm, MD, MSc  The Journal of Thoracic and Cardiovascular Surgery 
Yosuke Ishii, MD, PhD, Richard B. Schuessler, PhD, Sydney L
Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric.
Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy  Jiashing Yu,
Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: A pilot study  Wangde Dai,
What is the best material for extracardiac Fontan operation?
Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-β1 in healing rat vein grafts  Randal A Wolff, PhD, Jeffrey.
Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts 
Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia  Melina R. Kibbe, MDa,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice  Abbey Schepers, MD, Nuno M.M. Pires,
Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis.
Apples remain apples NO matter what
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Presentation transcript:

Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice  Afshin Ehsan, MD, Adam P. McGraw, PhD, Mark J. Aronovitz, MS, Carol Galayda, BS, Michael S. Conte, MD, Richard H. Karas, MD, PhD, Iris Z. Jaffe, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 6, Pages 1642-1649.e1 (June 2013) DOI: 10.1016/j.jtcvs.2012.08.007 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Expression of renin–angiotensin–aldosterone system (RAAS) components in human saphenous vein tissue and smooth muscle cells (HSVSMC). A, Quantitative reverse transcription–polymerase chain reaction was conducted to identify RAAS gene messenger RNA (mRNA) isolated from human saphenous vein (white bars) and HSVSMC (black bars). n = 4. B, Immunoblots on HSVSMC lysates with antibody specific for mineralocorticoid receptor (MR; top) and 11-β-hydroxysteroid dehydrogenase-2 (11βHSD2; bottom) protein. Lysate from HEK293 cells transfected with empty plasmid (−) or with plasmid that expresses MR or 11βHSD2 (+) serve as negative and positive controls, respectively. ND, Not detected; GR, glucocorticoid receptor; ACE, angiotensin-converting enzyme; AT1R, angiotensin type 1 receptor; AS, aldosterone synthase; MR, mineralocorticoid receptor. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1642-1649.e1DOI: (10.1016/j.jtcvs.2012.08.007) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Functional mineralocorticoid receptor (MR) in human saphenous vein smooth muscle cells (HSVSMC). Primary HSVSMC were infected with an adenovirus containing a mineralocorticoid-inducible response element–luciferase transcriptional reporter. A, Infected cells were treated with increasing doses of aldosterone (Aldo), and Aldo-induced changes in luciferase activity were measured. B, Cells were treated with 10 nM Aldo and/or the MR antagonist spironolactone (Spiro). Dash indicates reagents not added. *P < .05 versus vehicle. †P < .05 versus 10 nM Aldo. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1642-1649.e1DOI: (10.1016/j.jtcvs.2012.08.007) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Mineralocorticoid receptor antagonism reduces vein graft thickening in mice. A, Representative hematoxylin & eosin–stained sections from the native inferior vena cava (IVC) and throughout the grafted IVC from placebo- and spironolactone (Spiro)-treated mice. Images are arranged from proximal (left) to distal (right) orientation. Scale bar = 0.1 mm. B, Quantification of the intima–media area of the section with maximal vessel thickness (black boxes) in A from placebo- (white bar) and Spiro-treated (black bar) mice. *P < .05 versus placebo. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1642-1649.e1DOI: (10.1016/j.jtcvs.2012.08.007) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Vein graft smooth muscle cell (SMC) hyperplasia with mineralocorticoid receptor antagonism. Immunohistochemical staining of native and grafted inferior vena cava (IVC) sections using SMC-specific α-actin antibody. Actin-positive area and nuclei count in SMC actin-positive regions are quantified in vein sections from spironolactone-treated animals (black bars) and placebo-treated animals (white bars). Scale bar = 0.1 mm. *P < .05 versus placebo. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1642-1649.e1DOI: (10.1016/j.jtcvs.2012.08.007) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Inhibition of the mineralocorticoid receptor reduces vein graft fibrosis and inflammation. A, Quantification of vein graft trichrome-stained collagen area on the thickest sections from placebo- (white bars) and spironolactone (Spiro)-treated (black bars) mice. Scale bar = 0.1 mm. B, Quantification of inflammatory cells in high-power (40×) images of hematoxylin & eosin–stained sections of placebo- and spironolactone-treated animals. Representative mononuclear (MN) cells are indicated by white arrows; polymorphonuclear (PMN) cells are indicated by white asterisks. Scale bar = 0.02 mm. *P < .05 versus placebo. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1642-1649.e1DOI: (10.1016/j.jtcvs.2012.08.007) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions